Dana-Farber Cancer Institute
US H-1B Labor Condition Application activity for Dana-Farber Cancer Institute. Filed 1,926 disclosures between FY2010 and FY2026 from worksites with a MA headquarters indicator.
H-1B outcome breakdown
Share of Dana-Farber Cancer Institute’s LCAs by DOL case status, all fiscal years. Use the year filter above for a single-year breakdown.
| Outcome | Share |
|---|---|
| Certified | 74.1% |
| Cert-withdrawn | 22.8% |
| Withdrawn | 1.1% |
| Denied | 1.9% |
Top occupations sponsored
SOC codes filed most by Dana-Farber Cancer Institute across all fiscal years. Click any row to open the national salary guide.
| # | SOC | Title | Filings |
|---|---|---|---|
| 1 | 19-1042 | Medical Scientists, Except Epidemiologists | 569 |
| 2 | 19-1029 | Biological Scientists, All Other | 468 |
| 3 | 13-1161 | Market Research Analysts and Marketing Specialists | 330 |
| 4 | 19-4021 | Biological Technicians | 159 |
| 5 | 15-2041 | Statisticians | 59 |
| 6 | 29-1229 | Physicians, All Other | 40 |
| 7 | 29-2011 | Medical and Clinical Laboratory Technologists | 33 |
| 8 | 15-2051 | Data Scientists | 31 |
| 9 | 15-1252 | Software Developers | 27 |
| 10 | 19-2012 | Physicists | 25 |
H-1B filings by fiscal year
Year-over-year H-1B filing volume — a hiring-demand signal, not headcount.
| Year | Filings |
|---|---|
| FY2010 | 127 |
| FY2011 | 128 |
| FY2012 | 144 |
| FY2013 | 135 |
| FY2014 | 109 |
| FY2015 | 101 |
| FY2016 | 114 |
| FY2017 | 111 |
| FY2018 | 129 |
| FY2019 | 178 |
| FY2023 | 104 |
| FY2024 | 162 |
| FY2025 | 199 |
| FY2026 | 185 |
| Period | Value |
|---|---|
| FY2010 | 127 |
| FY2011 | 128 |
| FY2012 | 144 |
| FY2013 | 135 |
| FY2014 | 109 |
| FY2015 | 101 |
| FY2016 | 114 |
| FY2017 | 111 |
| FY2018 | 129 |
| FY2019 | 178 |
| FY2023 | 104 |
| FY2024 | 162 |
| FY2025 | 199 |
| FY2026 | 185 |
This employer filed at least one WARN Act notice in the last 24 months — a state-mandated advance announcement of a planned mass layoff or closure. A notice is an announcement, not a completed layoff, and it is not evidence of any link between the employer’s H-1B filings and its workforce plans.